Anti-immunoglobulin E for the treatment of allergic disease
2001; Lippincott Williams & Wilkins; Volume: 1; Issue: 1 Linguagem: Inglês
10.1097/01.all.0000010992.10510.21
ISSN1528-4050
AutoresWilliam W. Busse, William A Neaville,
Tópico(s)Food Allergy and Anaphylaxis Research
ResumoIgE plays a central role in allergic disease and participates in the associated inflammatory process. A mainstay of treatment of allergic disease, including asthma, is allergen avoidance and treatment of symptoms. Presently, the most effective treatments for allergic diseases are directed towards a regulation of the inflammatory process with corticosteroids. An exciting new approach is anti-IgE (rhuMAb-E25), which would regulate the allergic process at the level of IgE. The following information will review recent experiences with anti-IgE and discuss the conditions in which this approach may be effective.
Referência(s)